Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets

Completed · Phase 1

Conditions studied: Hypophosphatemic Rickets, X-Linked Dominant

In brief

This study will measure the effect of cinacalcet (Sensipar) on parathyroid hormone (PTH) secretion in children and adolescents with hypophosphatemic rickets (XLH). The investigators are seeking evidence that patients with XLH may benefit from treatment with cinacalcet by achieving better control of PTH secretion.

Key facts

Study ID

NCT00195936

Run by

Children's Mercy Hospital Kansas City

People needed

8

Starts

2005-06-01

Expected to finish

2008-02-01

Last updated by the study team

2021-01-19

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established patients with XLH
• Age 5 years old and above
• Normal serum calcium and creatinine concentrations

You may not qualify if…

• Patients with hypersensitivity to any component(s) of cinacalcet
• Hypocalcaemia
• Elevated serum creatinine

Where it is running

• Section of Pediatric Nephrology, Children's Mercy Hospitals and Clinics — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.